Atlas Trials

Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy

Clinical trial NCT05678322 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05678322
Sponsor
NYU Langone Health
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2023-01-31
Primary completion
2025-05-08
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.